Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 65,243,098 | 60,750,645 | 49,656,720 | 36,169,892 | 61,643,162 | 273,463,517 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 23,140,001 | 29,613,096 | 34,187,534 | 40,103,369 | 47,801,801 | 174,845,801 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 0 | |||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | |||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | 0 | |||||
| 6 | Total. Add lines 1 through 5 | 88,383,099 | 90,363,741 | 83,844,254 | 76,273,261 | 109,444,963 | 448,309,318 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | |||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 1,694,360 | 7,238,076 | 9,128,049 | 13,107,523 | 19,982,545 | 51,150,553 |
| c | Add lines 7a and 7b.. | 1,694,360 | 7,238,076 | 9,128,049 | 13,107,523 | 19,982,545 | 51,150,553 |
| 8 | Public support. (Subtract line 7c from line 6.) | 397,158,765 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 88,383,099 | 90,363,741 | 83,844,254 | 76,273,261 | 109,444,963 | 448,309,318 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 253,019 | 245,350 | 242,552 | 228,257 | 235,509 | 1,204,687 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | 0 | |||||
| c | Add lines 10a and 10b. | 253,019 | 245,350 | 242,552 | 228,257 | 235,509 | 1,204,687 |
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | 0 | |||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | 295,749 | 63,456 | 14,230 | 7,895 | 3,981 | 385,311 |
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 88,931,867 | 90,672,547 | 84,101,036 | 76,509,413 | 109,684,453 | 449,899,316 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2019 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2019 |
(iii) Distributable Amount for 2019 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2019 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2019: | ||||
| a From 2014....... | ||||
| b From 2015....... | ||||
| c From 2016....... | ||||
| d From 2017....... | ||||
| e From 2018....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2019 distributable amount | ||||
|
i
Carryover from 2014 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2019 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2019 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2019, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2019. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2020. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2015..... | ||||
| b Excess from 2016..... | ||||
| c Excess from 2017..... | ||||
| d Excess from 2018..... | ||||
| e Excess from 2019..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 1 | The Institute was established with the underlying purpose of "promot[ing] pure and applied sciences." Initially, as stated in the original Articles of Incorporation, this purpose was carried out through activities focused on the Midwest region and included specific provisions that the Institute would "improve and assist industry, agriculture and livestock production by the application of science," "conduct scientific investigations and industrial research for industry and agriculture,"foster the exchange of technical experience and research results among producers, manufacturers, agriculturists, and all others who may be benefited by the application of pure science." Over the years, while its underlying purpose has not changed, the Institute has evolved from a regionally focused scientific research and development organization to one of national and international scope. The purposes noted below reflect the broader scope of the current and foreseeable activities of the Institute. The Institute is organized exclusively for charitable, educational and scientific purposes within the meaning of Sections 501(c)(3) of the Internal Revenue Code of 1986, as amended, or the corresponding section or sections of any future United States Internal Revenue Law (the "Code"), including, for such purposes, the making of distributions to organizations that qualify as exempt organizations under Section 501(c)(3) of the Code. The Institute's purposes shall include the carrying on of scientific research and the utilization of scientific methods for the public interest; scientific research for cures for disease; scientific research for local, state, federal and international governments; scientific research which contributes to the development of the Kansas City region; scientific research for the benefit and education of humankind; and, in general, the promotion of basic (pure) and applied science and technology including, without limitation, the following specific activities: A. improve and assist industry by the application of science and technology, the conduct of scientific investigations and the conduct of industrial research; B. foster the exchange of technical experience and research results among producers, manufacturers, governmental agencies, educational organizations and all others who may benefit by the application of pure science; C. assist manufacturers, producers, and all others in the development of more efficient and scientific methods of production; D. advance defense locally, regionally, federally and internationally; E. advance the use of natural resources and other potential sources of energy by the application of science and technology; F. aid in the acquisition and dissemination of knowledge; G. collaborate with universities and educational institutions (through the awarding of scholarships, fellowships and grants or otherwise) to aid in the advancement of scientific education, to foster and encourage education and learning in science, to coordinate and develop experimental scientific and industrial research, and to promote liberal and practical education in the pursuit of scientific and industrial careers; and H. facilitate the introduction of scientific discoveries to the marketplace for the public benefit. To enable the Institute to carry out such purposes, it shall have the power to do any and all lawful acts and to engage in any and all lawful activities, directly or indirectly, alone or in conjunction with others, that might be necessary, proper or suitable for the attainment of any of the purposes for which the Institute is organized. |
| Form 990, Part III, Line 4a | Security and Defense (S&D): S&D is primarily involved in research and development, engineering, and program management in the areas of Countering Weapons of mass destruction; chemical and biological agent and explosive test, evaluation, and engineering; mobile laboratory design, fabrication, deployment, staffing, and support; forensic and source attribution analysis, independent instrumentation test and evaluation; and rapid prototyping. S&D supports field monitoring and forensics analysis programs in support of chemical, biological, radiological, nuclear, and explosives (Cbrne) missions. projects focused on the development of national security systems include mobile laboratory analytical systems, chemical containment systems, robotics systems and chemical sensors. The U.S. Government funds the majority of mriglobal's S&D work. |
| Form 990, Part III, Line 4b | Global Health and Security (GHS): ghs conducts bio-surveillance, biosafety, and biosecurity programs for the u.s. government. GHs's work depends on mriglobal's ability to work with regulated substances requiring high levels of oversight and certification. ghs is also involved in research and development in product development, repository management, diagnostics, medical countermeasures, pharmaceutical and vaccine development, and agriculture and food safety. The largest client sector is the u.s. government. ghs performs studies that target the development of therapeutics and vaccines under federally-mandated preparedness programs and in support of the pharmaceutical industry. ghs conducts analysis programs for biological pathogens and supports test and evaluation of emerging biotechnologies and clinical diagnostics. ghs also conducts programs to assess agriculture products requiring registration under epa's requirements. nih-sponsored programs for Niehs AND NCI are among GHS's largest clients. The focus of these research and development programs is chemical characterization, preparation of study articles, and repository management to support toxicology and pre-clinical studies. |
| Form 990, Part III, Line 4D | MRIGLOBAL'S OTHER PROGRAMS ARE ANCILLARY TO AND USUALLY COMPLEMENT THE SKILLS AND RESOURCES WITH S&D, GHS, AND ENERGY AND INFRASTRUCTURE. THE PRIMARY CUSTOMERS ARE AGENCIES OF THE U.S. GOVERNMENT. |
| FORM 990, PART VI, SECTION A, LINE 1A | GOVERNING BODY AND MANAGEMENT THE GOVERNING BODY HAS DELEGATED AUTHORITY TO ACT ON ITS BEHALF TO AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE MAY EXERCISE ANY AND ALL POWERS OF THE BOARD OF DIRECTORS SUBJECT TO THE PARAMOUNT POWER OF THE BOARD. THE EXECUTIVE COMMITTEE MAY CONVENE BETWEEN BOARD MEETINGS TO MAKE DECISIONS THAT CANNOT BE DELAYED UNTIL THE NEXT BOARD MEETING. THE EXECUTIVE COMMITTEE MEMBERS ARE ALL VOTING DIRECTORS. SPECIFICALLY, THE EXECUTIVE COMMITTEE IS COMPRISED OF THE CHAIR OF THE BOARD, VICE CHAIRS OF THE BOARD, CHAIR OF THE FINANCE AND AUDIT COMMITTEE, CHAIR OF THE NOMINATING AND GOVERNANCE COMMITTEE, CHAIR OF THE COMPENSATION AND HR COMMITTEE, AND THE MOST RECENT PAST CHAIR OF THE BOARD OF DIRECTORS, SO LONG AS HE OR SHE IS STILL A MEMBER OF THE BOARD OF DIRECTORS. |
| FORM 990, PART VI, SECTION A, LINE 2 | BUSINESS AND FAMILY RELATIONSHIPS MALCOM M. ASLIN AND STEPHEN GOUND HAVE A BUSINESS RELATIONSHIP. |
| FORM 990, PART VI, SECTION B, LINE 11B | REVIEW OF 990 PRIOR TO FILING THE 990 IS REVIEWED BY MRIGLOBAL STAFF, INCLUDING THE CFO, CONTROLLER, AND GENERAL COUNSEL. A FINAL DRAFT VERSION IS ALSO REVIEWED BY MRIGLOBAL'S FINANCE AND AUDIT COMMITTEE. EACH MEMBER OF THE BOARD OF DIRECTORS RECEIVES A FINAL DRAFT VERSION OF THE 990 PRIOR TO THE APPLICABLE BOARD OF DIRECTORS' MEETING. ANY UPDATES RESULTING FROM THE REVIEW BY THE FINANCE AND AUDIT COMMITTEE ARE PRESENTED TO THE BOARD OF DIRECTORS AT THIS MEETING. |
| FORM 990, PART VI, SECTION B, LINE 12C | MONITORING AND ENFORCEMENT OF BOARD INDEPENDENCE THE OFFICERS, DIRECTORS, TRUSTEES AND KEY EMPLOYEES OF MRIGLOBAL ARE REQUIRED TO COMPLETE A DISCLOSURE STATEMENT ON AN ANNUAL BASIS. THE DISCLOSURES SET FORTH ON THE STATEMENTS ARE PRESENTED TO THE FINANCE AND AUDIT COMMITTEE OF THE MRIGLOBAL BOARD OF DIRECTORS BY THE MRIGLOBAL COMPLIANCE OFFICER. THE FINANCE AND AUDIT COMMITTEE DISCUSSES THE DISCLOSURE STATEMENTS TO DETERMINE IF ANY POTENTIAL CONFLICT OF INTEREST SITUATIONS EXIST WITH RESPECT TO THE OFFICERS, DIRECTORS, TRUSTEES AND KEY EMPLOYEES OF MRIGLOBAL. AT THE FOLLOWING MRIGLOBAL BOARD MEETING, AN EXECUTIVE SUMMARY OF THE DISCLOSURE STATEMENTS IS PRESENTED TO THE DIRECTORS AND THE FINANCE AND AUDIT COMMITTEE REPORTS THE OUTCOME OF ITS DISCUSSION TO THE DIRECTORS. THE DIRECTORS ARE PRESENTED THE OPPORTUNITY TO DISCUSS THE FINANCE AND AUDIT COMMITTEE'S FINDINGS OR ANY OTHER POTENTIAL CONFLICT OF INTEREST ISSUES PRESENTED IN THE EXECUTIVE SUMMARY. ULTIMATELY, THE BOARD OF DIRECTORS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS WITH RESPECT TO ANY OFFICER, DIRECTOR, TRUSTEE OR KEY EMPLOYEE OF MRIGLOBAL. THE FINANCE AND AUDIT COMMITTEE'S FINDINGS AND THE DIRECTORS' DISCUSSION OF POTENTIAL CONFLICT OF INTEREST SITUATIONS ARE RECORDED IN THE MINUTES OF THE BOARD MEETING, INCLUDING DETERMINATION OF WHETHER A CONFLICT OF INTEREST EXISTS, THE NAMES OF THE INDIVIDUALS INVOLVED, THE NATURE OF THE POTENTIAL CONFLICT, THE ACTION TAKEN AND THE BASIS ON WHICH THE BOARD REACHED ITS DECISION. MRIGLOBAL HAS CERTAIN PROCEDURES WITH RESPECT TO ADDRESSING A CONFLICT OF INTEREST TRANSACTION. ANY ACTION TO BE TAKEN BY MRIGLOBAL INVOLVING OR PERTAINING TO AN INDIVIDUAL, ENTITY OR CIRCUMSTANCE WITH RESPECT TO WHICH AN OFFICER, DIRECTOR, TRUSTEE OR KEY EMPLOYEE (EACH, A COVERED PERSON) HAS A CONFLICTING INTEREST WILL BE DISCUSSED AND VOTED ON BY THE BOARD OF DIRECTORS. THE COVERED PERSON WILL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT THAT MAY RESULT IN A CONFLICT OF INTEREST. IN CONSIDERING ANY SUCH ACTION TO BE TAKEN, THE BOARD WILL UNDERTAKE APPROPRIATE DUE DILIGENCE AND INFORM ITSELF OF ALL MATERIAL INFORMATION REASONABLY AVAILABLE TO IT AND EXPLORE ALL REASONABLE ALTERNATIVES TO THE PROPOSED ACTION THAT WOULD NOT INVOLVE THE CONFLICT OF INTEREST. THE STANDARD FOR THE DETERMINATION OF WHETHER TO UNDERTAKE THE PROPOSED ACTION IS WHETHER SUCH ACTION IS, BASED ON A REASONABLE GOOD-FAITH BELIEF, (I) IN MRIGLOBAL'S BEST INTEREST, (II) FOR ITS OWN BENEFIT, AND (III) FAIR AND REASONABLE TO MRIGLOBAL. THE BOARD WILL DOCUMENT WHETHER OR NOT THE CONFLICT OF INTEREST TRANSACTION WAS APPROVED, THE NAMES OF THE PERSONS PRESENT FOR THE DISCUSSION AND VOTE, THE CONTENT OF THE DISCUSSION, WHETHER ALTERNATIVES WERE DISCUSSED THAT DID NOT INVOLVE A CONFLICT OF INTEREST, THE BASIS FOR THE DETERMINATION THAT THE TRANSACTION WAS (I) IN MRIGLOBAL'S BEST INTEREST, (II) FOR ITS OWN BENEFIT, AND (III) FAIR AND REASONABLE TO MRIGLOBAL, AND THE RECORD OF THE VOTE TAKEN WITH RESPECT TO WHO VOTED TO APPROVE THE TRANSACTION. IF THE BOARD HAS REASONABLE CAUSE TO BELIEVE THAT A COVERED PERSON HAS FAILED TO DISCLOSE A CONFLICT OF INTEREST SITUATION, IT WILL AFFORD THE COVERED PERSON AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. IF, AFTER HEARING THE RESPONSE OF THE COVERED PERSON AND MAKING SUCH FURTHER INVESTIGATION AS MAY BE WARRANTED UNDER THE CIRCUMSTANCES, THE BOARD DETERMINES THAT THE COVERED PERSON HAS IN FACT FAILED TO DISCLOSE A CONFLICT OF INTEREST SITUATION, IT WILL TAKE APPROPRIATE CORRECTIVE ACTION. THE MRIGLOBAL CONFLICT OF INTEREST POLICY REQUIRES THAT THE OFFICERS, DIRECTORS, TRUSTEES AND EMPLOYEES OF MRIGLOBAL DISCLOSE ANY POTENTIAL CONFLICT OF INTEREST SITUATION TO THE APPROPRIATE PARTY, INCLUDING AN EMPLOYEE'S SUPERVISOR, A REPRESENTATIVE OF HUMAN RESOURCES, THE COMPLIANCE OFFICER, THE BOARD OF DIRECTORS OR THE MRIGLOBAL ETHICS HOTLINE, UPON AWARENESS THAT A CONFLICT OF INTEREST MAY EXIST. POTENTIAL CONFLICT OF INTEREST SITUATIONS ASSOCIATED WITH EMPLOYEES (OTHER THAN OFFICERS, DIRECTORS, TRUSTEES AND KEY EMPLOYEES) ARE HANDLED BY THE MRIGLOBAL COMPLIANCE OFFICER, IN COLLABORATION WITH THE EMPLOYEE'S SUPERVISOR AND MRIGLOBAL EXECUTIVE MANAGEMENT, AS APPROPRIATE. ALL MRIGLOBAL EMPLOYEES ARE REQUIRED ON AN ANNUAL BASIS TO COMPLETE A COMPLIANCE QUESTIONNAIRE, WHICH AFFORDS THEM THE OPPORTUNITY TO DISCLOSE ANY POTENTIAL CONFLICT OF INTEREST SITUATIONS THAT HAVE NOT ALREADY BEEN REPORTED OR TO CERTIFY THAT THEY ARE NOT AWARE OF ANY POTENTIAL CONFLICT OF INTEREST SITUATIONS. FAILURE TO DISCLOSE A POTENTIAL CONFLICT OF INTEREST SITUATION MAY RESULT IN CORRECTIVE ACTION TO THE EMPLOYEE. |
| FORM 990, PART VI, SECTION B, LINE 15A & 15B | COMPENSATION OF OFFICERS, DIRECTORS, KEY EMPLOYEES MRIGLOBAL'S COMPENSATION AND HR COMMITTEE (COMMITTEE) OF THE BOARD OF DIRECTORS IS RESPONSIBLE FOR REVIEWING AND APPROVING EXECUTIVE COMPENSATION IN ALL AREAS. ON AN ANNUAL BASIS, THE COMMITTEE REVIEWS AND APPROVES COMPENSATION FOR EXECUTIVE OFFICERS OF THE INSTITUTE. THE COMMITTEE REVIEWS AND APPROVES THE CEO'S PERFORMANCE EVALUATIONS AND COMPENSATION RECOMMENDATIONS FOR THE EXECUTIVES. THE COMMITTEE IS INFORMED OF SUMMARY DATA ON THE INSTITUTE'S EMPLOYEE POPULATION (E.G. TOTAL PERSONNEL COSTS, EMPLOYEE DIVERSITY, TURNOVER, ETC.). THE COMMITTEE UTILIZES COMPENSATION SURVEY DATA, PROVIDED BY AN OUTSIDE PARTY, TO BENCHMARK COMPENSATION AGAINST SIMILARLY-SITUATED COMPANIES. THE COMMITTEE'S MINUTES DOCUMENT THE DECISIONS AND BASIS USED FOR MRIGLOBAL'S EXECUTIVE COMPENSATION. |
| FORM 990, PART VI, SECTION C, LINE 19 | GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, FINANCIAL STATEMENTS MRIGLOBAL'S GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. MRIGLOBAL'S CONFLICT OF INTEREST POLICY IS NOT MADE AVAILABLE TO THE PUBLIC. |
| FORM 990, PART XI, LINE 9 | OTHER CHANGES IN NET ASSETS PENSION ADJUSTMENT $ 4,475,487 EQUITY IN EARNINGS OF ALLIANCE LLC 3,340,048 IMPAIRMENT LOSS ( 156,130) ----------- $ 7,659,405 |
| Software ID: | |
| Software Version: |